Treatment with tetrahydrocannabinologists (THC) prevents inflammatory bowel disease (IBD) – Crohn’s disease and ulcerative colitis. Which, in turn, reduces the risk the development of colorectal cancer.
In a recent study by scientists from the University of South Carolina, it was found that treatment with tetrahydrocannabinol (THC) (a substance found in hemp) prevents the development of colon cancer in mice. It was found that THC suppresses inflammation in the colon, preventing the development of tumors that appear due to carcinogens.
“The fact that we were able to show that treatment with THC prevents inflammation in the colon while suppressing the development of cancer supports the notion that inflammation and cancer are closely related. Patients at a higher risk of developing colon cancer, THC or other anti-inflammatory agents may be helpful, “said Prakash Nagarkatti, MD, one of the authors of the project.
Cancer Prevention – Formerly Glavred reported: